We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+2.85%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$14.8B
AUM Growth
+$2.92B
(+25%)
Cap. Flow
+$3.28B
Cap. Flow
% of AUM
22.14%
Top 10 Holdings %
Top 10 Hldgs %
12.56%
Holding
1,029
New
443
Increased
269
Reduced
185
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$217M |
| 2 |
Apple
AAPL
|
+$208M |
| 3 |
Microsoft
MSFT
|
+$199M |
| 4 |
Amazon
AMZN
|
+$136M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$125M |
| 2 |
Gilead Sciences
GILD
|
+$107M |
| 3 |
PR
Permian Resources
PR
|
+$85.4M |
| 4 |
Reddit
RDDT
|
+$84.1M |
| 5 |
Keysight
KEYS
|
+$79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.96% |
| 2 | Technology | 25.64% |
| 3 | Financials | 7.58% |
| 4 | Industrials | 6.88% |
| 5 | Communication Services | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Dave & Buster's
PLAY
$360M
| $6.7M | 0.05% |
+229,609
| New | +$7.99M |
|
|
SCHW
427
Charles Schwab
SCHW
$186B
| $6.64M | 0.04% |
+89,776
| New | +$6.72M |
|
428
Cloudflare
NET
$102B
| $6.64M | 0.04% |
+61,646
| New | +$6.02M |
|
429
Fulcrum Therapeutics
FULC
$285M
| $6.63M | 0.04% |
1,410,520
+739,713
| +110% | +$2.73M |
|
430
Dianthus Therapeutics
DNTH
$6.11B
| $6.55M | 0.04% |
300,504
+50,000
| +20% | +$1.29M |
|
431
Revolve Group
RVLV
$1.75B
| $6.48M | 0.04% |
+193,391
| New | +$5.99M |
|
432
Deere & Co
DE
$166B
| $6.47M | 0.04% |
+15,281
| New | +$6.44M |
|
433
Spectrum Brands
SPB
$2.08B
| $6.45M | 0.04% |
76,398
-35,499
| -32% | -$3.21M |
|
434
AnaptysBio
ANAB
$1.63B
| $6.42M | 0.04% |
485,073
+25,094
| +5% | +$608K |
|
435
CACI
CACI
$13.7B
| $6.4M | 0.04% |
+15,831
| New | +$7.72M |
|
436
Nurix Therapeutics
NRIX
$2.59B
| $6.38M | 0.04% |
338,462
+1,583
| +0.5% | +$36.3K |
|
437
Carrier Global
CARR
$53.7B
| $6.38M | 0.04% |
+93,409
| New | +$7.05M |
|
438
West Pharmaceutical
WST
$24.5B
| $6.37M | 0.04% |
+19,454
| New | +$6.12M |
|
439
CrowdStrike
CRWD
$210B
| $6.35M | 0.04% |
74,180
+33,148
| +81% | +$2.76M |
|
|
DEC
440
Diversified Energy Company
DEC
$912M
| $6.27M | 0.04% |
+373,447
| New | +$5.21M |
|
441
Loar Holdings
LOAR
$6.91B
| $6.2M | 0.04% |
83,928
+51,149
| +156% | +$4.19M |
|
442
Ametek
AME
$57.6B
| $6.19M | 0.04% |
34,357
+30,889
| +891% | +$5.63M |
|
443
Keros Therapeutics
KROS
$201M
| $6.14M | 0.04% |
387,701
-375,847
| -49% | -$19.5M |
|
|
ATYR
444
aTyr Pharma
ATYR
$48.9M
| $6.09M | 0.04% |
1,683,000
-549
| -0% | -$1.66K |
|
445
Thermo Fisher Scientific
TMO
$212B
| $6.09M | 0.04% |
+11,699
| New | +$6.43M |
|
|
APLS
446
DELISTED
Apellis Pharmaceuticals
APLS
| $6.05M | 0.04% |
189,477
+913
| +0.5% | +$27.5K |
|
447
Tarsus Pharmaceuticals
TARS
$2.84B
| $6.03M | 0.04% |
108,986
+37,417
| +52% | +$1.7M |
|
448
Penumbra
PEN
$12.8B
| $6.01M | 0.04% |
25,323
+20,218
| +396% | +$4.6M |
|
|
TECX
449
Tectonic Therapeutic
TECX
$567M
| $6.01M | 0.04% |
130,109
+64,661
| +99% | +$2.73M |
|
450
Western Digital
WDC
$164B
| $6M | 0.04% |
133,107
+81,632
| +159% | +$4.1M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Woodline Partners held 1,029 positions worth $14.8B, up 25% from $11.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Woodline Partners deployed $3.28B of net new capital in Q4 2024, opening 443 new positions and adding to 269 existing holdings. Its largest new stake was TE Connectivity: 890,754 shares worth $127M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 43% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $107M trimmed.
- Woodline Partners's largest Q4 2024 buy was TE Connectivity: 890,754 shares worth $127M.
- Woodline Partners added most to NVIDIA in Q4 2024, an estimated $217M increase.
- Woodline Partners's biggest Q4 2024 reduction was Gilead Sciences, cutting an estimated $107M.
- Woodline Partners fully exited ASML in Q4 2024, selling an estimated $125M.
- Woodline Partners's ten largest holdings make up 13% of its $14.8B portfolio in Q4 2024.
- Woodline Partners opened 443 new positions and closed 112 in Q4 2024.
- Woodline Partners's portfolio value rose 25% quarter-over-quarter to $14.8B.
Based on Woodline Partners's 13F filing for Q4 2024, filed 14 Feb 2025.